Mabaruma was constituted a town. The High Court held that refusing an accused the chance to cross-examine prosecution witnesses breached the Constitution, and rejected a pharmaceutical distributor’s discrimination claim over a Ministry of Health prequalification.
The Mabaruma Town (Constitution) Order 2015 (Order No. 18), gazetted on 21 October, establishes Mabaruma as a town, with a body corporate called the Mayor and Town Council of Mabaruma, consisting of a Mayor, a Deputy Mayor and between ten and fourteen other councillors.
On 15 October, in Walsh v Ward [2015] CCJ 14 (AJ), a Barbados appeal over the sale of a plantation, the CCJ held that a claimant who had farmed the land in expectation of buying it was not entitled to specific performance, since he had not paid the deposit. It added that, although nothing turned on it, two judges of the Court of Appeal should have recused themselves after a request based on perceived bias.
On 30 October, in Maya Leaders Alliance v Attorney General of Belize [2015] CCJ 15 (AJ), the parties had already agreed by a consent order in April that Maya customary land tenure in the Toledo District gives rise to property rights protected by the Belize Constitution. The CCJ held that the Government had breached the appellants’ right to protection of the law by failing to ensure that the property regime recognised and protected those rights, and ordered it to establish a fund of BZ$300,000 as a first step towards meeting its undertaking to protect Maya customary land tenure.
From the Guyana Courts
On 21 October the acting Chief Justice held that a magistrate’s refusal to let a person charged under the Sexual Offences Act cross-examine the prosecution witnesses breached article 144(1) and (2) of the Constitution. Article 144(2)(e) imposes a positive duty to facilitate the examination of prosecution witnesses by the accused or his legal representative.
In International Pharmaceutical Agency Guyana Ltd v Attorney General, a decision the report dates 2 October, the court rejected a claim that the Ministry of Health’s revised criteria for prequalifying suppliers of pharmaceuticals discriminated against the applicant on a ground prohibited by article 149(2) of the Constitution.
The accounts of the High Court decisions are taken from the reports at [2015] GLR 318 and 274. The report of International Pharmaceutical Agency misprints the year of the decision, and its date has not been verified.
This commentary is general information, not legal advice.
